|
Akt2
an AGC kinase. Plays critical roles in glucose metabolism and the development or maintenance of proper adipose tissue and islet mass for which other Akt/PKB isoforms are unable to fully compensate. Amplified and overexpressed in human ovarian carcinoma cell lines and amplified in some primary ovarian and pancreatic tumors. Antisense blocks invasiveness in xenografts. Expressed in several insulin-responsive tissues, and one case of Type II diabetes has been associated with a likely LOF point mutation. Mouse mutants have defects in insulin response. Note: This description may include information from UniProtKB.
|
| Protein type: Protein kinase, AGC; Protein kinase, Ser/Thr (non-receptor); Kinase, protein; EC 2.7.11.1; AGC group; AKT family |
|
Cellular Component: membrane; intracellular membrane-bound organelle; lamellipodium; cytoplasm; plasma membrane; nucleus; cytosol; vesicle
|
|
Molecular Function: transferase activity; protein serine/threonine kinase activity; protein binding; protein kinase C binding; transferase activity, transferring phosphorus-containing groups; nucleotide binding; phospholipid binding; kinase activity; ATP binding; protein kinase activity
|
|
Biological Process: glycogen metabolic process; positive regulation of positive chemotaxis; positive regulation of nitric oxide biosynthetic process; apoptosis; multicellular organismal development; positive regulation of glycogen biosynthetic process; negative regulation of caspase activity; regulation of JNK cascade; protein amino acid phosphorylation; regulation of translation; positive regulation of glucose import; negative regulation of RNA splicing; transport; protein kinase B signaling cascade; activation of Ral GTPase; glycogen biosynthetic process; positive regulation of signal transduction; carbohydrate transport; myelin maintenance in the peripheral nervous system; glucose metabolic process; positive regulation of peptidyl-serine phosphorylation; positive regulation of fatty acid beta-oxidation; cellular response to insulin stimulus; carbohydrate metabolic process; insulin receptor signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of protein amino acid phosphorylation; phosphorylation; positive regulation of cell migration; negative regulation of apoptosis
|
|
Reference #:
Q60823 (UniProtKB)
|
| Alt. Names/Synonyms: 2410016A19Rik; Akt2; AW554154; MGC14031; OTTMUSP00000017783; OTTMUSP00000017784; OTTMUSP00000017785; PKB; PKB beta; PKBbeta; Protein kinase Akt-2; Protein kinase B beta; protein kinase B, beta; RAC-beta serine/threonine protein kinase; RAC-beta serine/threonine-protein kinase; RAC-PK-beta; thymoma viral proto-oncogene 2 |
| Gene Symbols: Akt2 |
|
Molecular weight: 55,742 Da
|
|
Basal Isoelectric point: 5.98
Predict pI for various phosphorylation states
|
|
CST Pathways:
Adherens Junction Dynamics
|
Alzheimer's Disease
|
AMPK Signaling
|
Angiogenesis
|
Apoptosis
|
B Cell Receptor Signaling
|
Cell Cycle: G1/S Checkpoint
|
ErbB/HER Signaling
|
ESC Pluripotency and Differentiation
|
Inhibition of Apoptosis
|
Insulin Receptor Signaling
|
Jak/Stat/IL-6 Signaling
|
Mitochondrial Control of Apoptosis
|
mTOR Signaling
|
NF-kB Signaling
|
PI3K/Akt Signaling
|
Protein Kinase C Signaling
|
Regulation of Microtubule Dynamics
|
T Cell Receptor Signaling
|
TGF-ß Signaling
|
Translation: eIF4E and p70S6K
|
Warburg Effect
|
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology®
|